Sage Therapeutics Reports Disappointing Study Results for Alzheimer’s Treatment Sage Therapeutics Reports Disappointing Study Results for Alzheimer’s Treatment · Barrons.com Emily Dattilo Tue, Oct 8, 2024, 7:53 AM 1 min read In This Article: SAGE +4.99% The biopharmaceutical company isn’t planning further clinical development of dalzanemdor to treat Alzheimer’s. Continue Reading View Comments Terms and Privacy Policy WA Consumer Health Privacy Policy Your privacy controls Recommended Stories